Compare EVI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVI | OBIO |
|---|---|---|
| Founded | 1959 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 240.7M |
| IPO Year | 1995 | 2020 |
| Metric | EVI | OBIO |
|---|---|---|
| Price | $15.34 | $3.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $35.00 | $14.25 |
| AVG Volume (30 Days) | 83.9K | ★ 535.0K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | 32.43 | ★ 33.13 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $389,830,000.00 | $33,482,000.00 |
| Revenue This Year | $15.53 | N/A |
| Revenue Next Year | $3.83 | $12.43 |
| P/E Ratio | $49.55 | ★ N/A |
| Revenue Growth | 10.26 | ★ 1169.22 |
| 52 Week Low | $14.06 | $2.20 |
| 52 Week High | $34.82 | $5.42 |
| Indicator | EVI | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 45.34 |
| Support Level | $14.06 | $3.47 |
| Resistance Level | $21.36 | $4.18 |
| Average True Range (ATR) | 0.92 | 0.28 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 43.90 | 12.53 |
EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.